Share Price and Basic Stock Data
Last Updated: November 8, 2025, 3:22 am
| PEG Ratio | 0.45 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Narmada Agrobase Ltd operates in the animal and shrimp feed industry, focusing on providing high-quality feed products. As of the latest reporting, the company’s share price stood at ₹23.9, with a market capitalization of ₹90.6 Cr. The revenue from operations for the fiscal year ending March 2025 reported a substantial increase to ₹64.68 Cr, compared to ₹49.48 Cr in March 2023. This trend reflects a consistent recovery post-pandemic, with quarterly sales demonstrating variability; for instance, the sales in March 2024 reached ₹18.75 Cr, while the subsequent quarter recorded ₹12.26 Cr. Despite fluctuations, the overall trajectory indicates a positive growth pattern in revenue generation, supported by strategic operational enhancements and market demand. The company’s sales performance is indicative of its adaptability within the competitive landscape of the feed industry, which has generally experienced growth in recent years.
Profitability and Efficiency Metrics
Narmada Agrobase reported an operating profit margin (OPM) of 11.91% for the fiscal year ending March 2025, reflecting a significant improvement from previous periods. The company’s net profit for the same fiscal year rose to ₹4.09 Cr, showcasing enhanced profitability driven by effective cost management and operational efficiencies. The interest coverage ratio (ICR) stood at 7.44x, indicating a strong ability to meet interest obligations, a crucial metric for assessing financial health. The return on equity (ROE) was reported at 11.2%, while return on capital employed (ROCE) improved to 13.0%, both reflecting a strong return generation capability relative to its equity and capital investments. However, the cash conversion cycle (CCC) extended to 260.66 days, suggesting potential inefficiencies in working capital management, which could impact liquidity if not addressed.
Balance Sheet Strength and Financial Ratios
Narmada Agrobase’s balance sheet reveals a healthy structure, with total assets reported at ₹66.46 Cr for March 2025, supported by reserves of ₹17.93 Cr and borrowings of ₹9.47 Cr. The company’s debt-to-equity ratio stood at 0.16, indicating a conservative approach to leveraging, which is favorable in maintaining financial stability. The current ratio of 6.21x highlights robust liquidity, well above the typical sector benchmark, ensuring the company can cover its short-term obligations comfortably. The interest coverage ratio of 7.44x further underscores its ability to meet interest payments from operational earnings. However, the rising inventory days, which reached 154.49 days in March 2025, could pose challenges in terms of cash flow management and indicate a need for better inventory control practices.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Narmada Agrobase demonstrates a notable shift, with promoters holding 50.30% of the equity as of March 2025, down from 66.47% in December 2022. This reduction may indicate a dilution of control but also reflects increased public interest, as public shareholding rose to 40.74%. The presence of domestic institutional investors (DIIs) at 8.96% signifies a growing institutional confidence in the company’s potential. The total number of shareholders increased to 11,308, suggesting a positive reception from retail investors and a broader market appeal. In contrast, the absence of foreign institutional investors (FIIs) could limit the company’s exposure to international capital, which may affect its growth strategy in the long term.
Outlook, Risks, and Final Insight
Looking ahead, Narmada Agrobase Ltd’s growth outlook appears optimistic, given its strong revenue trajectory and improving profitability metrics. However, risks such as the extended cash conversion cycle and fluctuating sales could hinder operational efficiency if not managed effectively. The company must focus on optimizing inventory management and enhancing working capital practices to mitigate potential liquidity concerns. Additionally, the decline in promoter holding could raise questions about long-term strategic direction, potentially impacting investor sentiment. Should Narmada Agrobase successfully address these challenges while capitalizing on market opportunities, it stands to enhance its competitive positioning in the animal feed sector. Overall, a balanced approach to managing growth and risks will be crucial for sustaining momentum in the coming years.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Narmada Agrobase Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Narmada Agrobase Ltd | 86.4 Cr. | 22.8 | 28.4/14.6 | 21.1 | 14.7 | 0.00 % | 13.0 % | 11.2 % | 10.0 |
| Godrej Agrovet Ltd | 11,339 Cr. | 590 | 876/587 | 26.0 | 94.1 | 1.87 % | 16.6 % | 17.7 % | 10.0 |
| Avanti Feeds Ltd | 9,509 Cr. | 698 | 965/563 | 15.4 | 221 | 1.29 % | 24.0 % | 19.5 % | 1.00 |
| Ajooni Biotech Ltd | 85.1 Cr. | 4.94 | 8.55/4.80 | 23.2 | 5.11 | 0.00 % | 6.91 % | 5.15 % | 2.00 |
| Industry Average | 10,424.00 Cr | 328.94 | 21.43 | 83.73 | 0.79% | 15.13% | 13.39% | 5.75 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 7.91 | 13.24 | 10.62 | 18.26 | 7.95 | 11.41 | 12.22 | 18.75 | 12.26 | 10.28 | 13.84 | 29.30 | 11.08 |
| Expenses | 7.52 | 12.61 | 10.06 | 17.81 | 7.50 | 10.94 | 11.77 | 17.60 | 10.68 | 8.21 | 12.50 | 28.71 | 9.76 |
| Operating Profit | 0.39 | 0.63 | 0.56 | 0.45 | 0.45 | 0.47 | 0.45 | 1.15 | 1.58 | 2.07 | 1.34 | 0.59 | 1.32 |
| OPM % | 4.93% | 4.76% | 5.27% | 2.46% | 5.66% | 4.12% | 3.68% | 6.13% | 12.89% | 20.14% | 9.68% | 2.01% | 11.91% |
| Other Income | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | 0.02 | 0.00 | 0.01 | 0.01 | 0.32 | 0.32 | 0.33 |
| Interest | 0.20 | 0.19 | 0.22 | 0.25 | 0.23 | 0.23 | 0.23 | 0.26 | 0.24 | 0.24 | 0.21 | 0.16 | 0.24 |
| Depreciation | 0.08 | 0.08 | 0.08 | 0.08 | 0.07 | 0.07 | 0.07 | 0.07 | 0.06 | 0.06 | 0.06 | 0.06 | 0.05 |
| Profit before tax | 0.12 | 0.37 | 0.27 | 0.13 | 0.16 | 0.20 | 0.17 | 0.82 | 1.29 | 1.78 | 1.39 | 0.69 | 1.36 |
| Tax % | 33.33% | 27.03% | 25.93% | 23.08% | 31.25% | 15.00% | 23.53% | 25.61% | 21.71% | 26.97% | 28.06% | -13.04% | 25.00% |
| Net Profit | 0.08 | 0.27 | 0.20 | 0.10 | 0.11 | 0.17 | 0.13 | 0.61 | 1.02 | 1.29 | 1.00 | 0.78 | 1.02 |
| EPS in Rs | 0.02 | 0.07 | 0.05 | 0.03 | 0.03 | 0.04 | 0.03 | 0.16 | 0.27 | 0.34 | 0.26 | 0.21 | 0.27 |
Last Updated: August 20, 2025, 6:25 am
Below is a detailed analysis of the quarterly data for Narmada Agrobase Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 11.08 Cr.. The value appears to be declining and may need further review. It has decreased from 29.30 Cr. (Mar 2025) to 11.08 Cr., marking a decrease of 18.22 Cr..
- For Expenses, as of Jun 2025, the value is 9.76 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 28.71 Cr. (Mar 2025) to 9.76 Cr., marking a decrease of 18.95 Cr..
- For Operating Profit, as of Jun 2025, the value is 1.32 Cr.. The value appears strong and on an upward trend. It has increased from 0.59 Cr. (Mar 2025) to 1.32 Cr., marking an increase of 0.73 Cr..
- For OPM %, as of Jun 2025, the value is 11.91%. The value appears strong and on an upward trend. It has increased from 2.01% (Mar 2025) to 11.91%, marking an increase of 9.90%.
- For Other Income, as of Jun 2025, the value is 0.33 Cr.. The value appears strong and on an upward trend. It has increased from 0.32 Cr. (Mar 2025) to 0.33 Cr., marking an increase of 0.01 Cr..
- For Interest, as of Jun 2025, the value is 0.24 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.16 Cr. (Mar 2025) to 0.24 Cr., marking an increase of 0.08 Cr..
- For Depreciation, as of Jun 2025, the value is 0.05 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.06 Cr. (Mar 2025) to 0.05 Cr., marking a decrease of 0.01 Cr..
- For Profit before tax, as of Jun 2025, the value is 1.36 Cr.. The value appears strong and on an upward trend. It has increased from 0.69 Cr. (Mar 2025) to 1.36 Cr., marking an increase of 0.67 Cr..
- For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from -13.04% (Mar 2025) to 25.00%, marking an increase of 38.04%.
- For Net Profit, as of Jun 2025, the value is 1.02 Cr.. The value appears strong and on an upward trend. It has increased from 0.78 Cr. (Mar 2025) to 1.02 Cr., marking an increase of 0.24 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.27. The value appears strong and on an upward trend. It has increased from 0.21 (Mar 2025) to 0.27, marking an increase of 0.06.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:47 am
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 21.97 | 30.53 | 34.45 | 37.00 | 47.50 | 61.46 | 58.14 | 34.61 | 49.48 | 49.74 | 64.68 | 64.50 |
| Expenses | 21.12 | 29.35 | 33.02 | 35.43 | 45.87 | 59.00 | 55.90 | 32.61 | 47.46 | 47.22 | 59.10 | 59.18 |
| Operating Profit | 0.85 | 1.18 | 1.43 | 1.57 | 1.63 | 2.46 | 2.24 | 2.00 | 2.02 | 2.52 | 5.58 | 5.32 |
| OPM % | 3.87% | 3.87% | 4.15% | 4.24% | 3.43% | 4.00% | 3.85% | 5.78% | 4.08% | 5.07% | 8.63% | 8.25% |
| Other Income | 0.02 | 0.02 | 0.02 | 0.07 | 0.28 | 0.03 | 0.04 | 0.06 | 0.05 | 0.07 | 0.66 | 0.98 |
| Interest | 0.43 | 0.70 | 0.75 | 0.82 | 0.70 | 1.03 | 0.85 | 0.82 | 0.86 | 0.96 | 0.84 | 0.85 |
| Depreciation | 0.27 | 0.27 | 0.30 | 0.28 | 0.54 | 0.40 | 0.42 | 0.37 | 0.32 | 0.28 | 0.24 | 0.23 |
| Profit before tax | 0.17 | 0.23 | 0.40 | 0.54 | 0.67 | 1.06 | 1.01 | 0.87 | 0.89 | 1.35 | 5.16 | 5.22 |
| Tax % | 17.65% | 21.74% | 25.00% | 25.93% | 25.37% | 25.47% | 32.67% | 31.03% | 26.97% | 24.44% | 20.74% | |
| Net Profit | 0.14 | 0.19 | 0.30 | 0.40 | 0.50 | 0.79 | 0.68 | 0.61 | 0.65 | 1.02 | 4.09 | 4.09 |
| EPS in Rs | 0.22 | 0.21 | 0.33 | 0.15 | 0.13 | 0.21 | 0.18 | 0.16 | 0.17 | 0.27 | 1.08 | 1.08 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 15.06% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 35.71% | 57.89% | 33.33% | 25.00% | 58.00% | -13.92% | -10.29% | 6.56% | 56.92% | 300.98% |
| Change in YoY Net Profit Growth (%) | 0.00% | 22.18% | -24.56% | -8.33% | 33.00% | -71.92% | 3.63% | 16.85% | 50.37% | 244.06% |
Narmada Agrobase Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 1% |
| 3 Years: | 24% |
| TTM: | 18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 40% |
| 5 Years: | 39% |
| 3 Years: | 89% |
| TTM: | 112% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 15% |
| 3 Years: | 10% |
| 1 Year: | 31% |
| Return on Equity | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 7% |
| 3 Years: | 8% |
| Last Year: | 11% |
Last Updated: September 5, 2025, 11:30 am
Balance Sheet
Last Updated: June 16, 2025, 11:39 am
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1.25 | 1.83 | 1.83 | 5.19 | 7.53 | 13.55 | 13.55 | 13.55 | 13.55 | 13.55 | 37.94 |
| Reserves | 0.11 | 0.30 | 0.64 | 0.42 | 6.04 | 0.71 | 1.39 | 1.68 | 2.33 | 3.35 | 17.93 |
| Borrowings | 6.71 | 7.93 | 10.22 | 7.39 | 9.13 | 8.44 | 8.69 | 9.72 | 10.07 | 9.68 | 9.47 |
| Other Liabilities | 0.89 | 0.67 | 0.98 | 1.44 | 0.88 | 1.57 | 3.29 | 1.55 | 1.37 | 1.38 | 1.12 |
| Total Liabilities | 8.96 | 10.73 | 13.67 | 14.44 | 23.58 | 24.27 | 26.92 | 26.50 | 27.32 | 27.96 | 66.46 |
| Fixed Assets | 2.38 | 2.71 | 2.66 | 2.74 | 4.66 | 3.89 | 3.50 | 3.75 | 3.44 | 3.18 | 2.97 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
| Investments | 0.21 | 0.21 | 0.43 | 0.47 | 0.61 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 6.37 | 7.81 | 10.58 | 11.23 | 18.31 | 20.38 | 23.42 | 22.75 | 23.88 | 24.78 | 63.47 |
| Total Assets | 8.96 | 10.73 | 13.67 | 14.44 | 23.58 | 24.27 | 26.92 | 26.50 | 27.32 | 27.96 | 66.46 |
Below is a detailed analysis of the balance sheet data for Narmada Agrobase Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 37.94 Cr.. The value appears strong and on an upward trend. It has increased from 13.55 Cr. (Mar 2024) to 37.94 Cr., marking an increase of 24.39 Cr..
- For Reserves, as of Mar 2025, the value is 17.93 Cr.. The value appears strong and on an upward trend. It has increased from 3.35 Cr. (Mar 2024) to 17.93 Cr., marking an increase of 14.58 Cr..
- For Borrowings, as of Mar 2025, the value is 9.47 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 9.68 Cr. (Mar 2024) to 9.47 Cr., marking a decrease of 0.21 Cr..
- For Other Liabilities, as of Mar 2025, the value is 1.12 Cr.. The value appears to be improving (decreasing). It has decreased from 1.38 Cr. (Mar 2024) to 1.12 Cr., marking a decrease of 0.26 Cr..
- For Total Liabilities, as of Mar 2025, the value is 66.46 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 27.96 Cr. (Mar 2024) to 66.46 Cr., marking an increase of 38.50 Cr..
- For Fixed Assets, as of Mar 2025, the value is 2.97 Cr.. The value appears to be declining and may need further review. It has decreased from 3.18 Cr. (Mar 2024) to 2.97 Cr., marking a decrease of 0.21 Cr..
- For CWIP, as of Mar 2025, the value is 0.02 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 0.02 Cr., marking an increase of 0.02 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 63.47 Cr.. The value appears strong and on an upward trend. It has increased from 24.78 Cr. (Mar 2024) to 63.47 Cr., marking an increase of 38.69 Cr..
- For Total Assets, as of Mar 2025, the value is 66.46 Cr.. The value appears strong and on an upward trend. It has increased from 27.96 Cr. (Mar 2024) to 66.46 Cr., marking an increase of 38.50 Cr..
Notably, the Reserves (17.93 Cr.) exceed the Borrowings (9.47 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -5.86 | -6.75 | -8.79 | -5.82 | -7.50 | -5.98 | -6.45 | -7.72 | -8.05 | -7.16 | -3.89 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 30.07 | 26.66 | 31.89 | 31.07 | 58.02 | 67.41 | 101.83 | 151.97 | 97.52 | 97.74 | 107.56 |
| Inventory Days | 73.60 | 54.43 | 70.88 | 75.62 | 70.33 | 37.81 | 28.83 | 77.66 | 75.95 | 84.67 | 154.49 |
| Days Payable | 10.54 | 6.97 | 8.63 | 11.98 | 3.54 | 4.02 | 15.92 | 10.03 | 7.25 | 6.35 | 1.38 |
| Cash Conversion Cycle | 93.13 | 74.11 | 94.14 | 94.71 | 124.80 | 101.19 | 114.74 | 219.59 | 166.22 | 176.06 | 260.66 |
| Working Capital Days | 21.27 | 25.70 | 26.81 | 25.35 | 59.01 | 53.09 | 64.10 | 104.62 | 87.34 | 94.00 | 194.58 |
| ROCE % | 10.26% | 10.11% | 10.59% | 7.68% | 9.21% | 8.20% | 6.96% | 6.88% | 8.79% | 13.05% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 1.56 | 0.75 | 0.48 | 0.41 | 0.56 |
| Diluted EPS (Rs.) | 1.56 | 0.75 | 0.48 | 0.41 | 0.56 |
| Cash EPS (Rs.) | 1.14 | 0.95 | 0.71 | 0.67 | 0.86 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 14.73 | 12.47 | 11.72 | 11.43 | 11.03 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 14.73 | 12.47 | 11.72 | 11.43 | 11.03 |
| Revenue From Operations / Share (Rs.) | 17.31 | 37.14 | 36.92 | 25.81 | 43.00 |
| PBDIT / Share (Rs.) | 1.64 | 1.91 | 1.53 | 1.46 | 1.68 |
| PBIT / Share (Rs.) | 1.58 | 1.71 | 1.29 | 1.19 | 1.37 |
| PBT / Share (Rs.) | 1.36 | 0.99 | 0.65 | 0.58 | 0.74 |
| Net Profit / Share (Rs.) | 1.08 | 0.75 | 0.48 | 0.40 | 0.55 |
| PBDIT Margin (%) | 9.49 | 5.14 | 4.13 | 5.64 | 3.91 |
| PBIT Margin (%) | 9.12 | 4.59 | 3.50 | 4.59 | 3.19 |
| PBT Margin (%) | 7.85 | 2.68 | 1.77 | 2.27 | 1.73 |
| Net Profit Margin (%) | 6.22 | 2.02 | 1.30 | 1.57 | 1.29 |
| Return on Networth / Equity (%) | 7.31 | 6.03 | 4.10 | 3.55 | 5.04 |
| Return on Capital Employeed (%) | 10.51 | 13.60 | 10.65 | 10.29 | 11.67 |
| Return On Assets (%) | 6.15 | 3.64 | 2.38 | 2.04 | 2.80 |
| Long Term Debt / Equity (X) | 0.02 | 0.01 | 0.03 | 0.00 | 0.05 |
| Total Debt / Equity (X) | 0.16 | 0.57 | 0.63 | 0.62 | 0.53 |
| Asset Turnover Ratio (%) | 1.39 | 1.82 | 1.85 | 1.30 | 2.29 |
| Current Ratio (X) | 6.21 | 2.24 | 2.14 | 1.97 | 1.96 |
| Quick Ratio (X) | 3.73 | 1.33 | 1.31 | 1.41 | 1.59 |
| Inventory Turnover Ratio (X) | 3.25 | 4.58 | 5.67 | 5.72 | 10.22 |
| Interest Coverage Ratio (X) | 7.44 | 2.70 | 2.40 | 2.43 | 2.67 |
| Interest Coverage Ratio (Post Tax) (X) | 5.88 | 2.06 | 1.76 | 1.68 | 1.88 |
| Enterprise Value (Cr.) | 56.46 | 36.45 | 40.59 | 36.04 | 21.25 |
| EV / Net Operating Revenue (X) | 0.85 | 0.72 | 0.81 | 1.03 | 0.36 |
| EV / EBITDA (X) | 9.05 | 14.08 | 19.62 | 18.26 | 9.31 |
| MarketCap / Net Operating Revenue (X) | 0.94 | 0.54 | 0.62 | 0.77 | 0.23 |
| Price / BV (X) | 1.11 | 1.63 | 1.96 | 1.74 | 0.92 |
| Price / Net Operating Revenue (X) | 0.94 | 0.54 | 0.62 | 0.77 | 0.23 |
| EarningsYield | 0.06 | 0.03 | 0.02 | 0.02 | 0.05 |
After reviewing the key financial ratios for Narmada Agrobase Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 1.56. This value is below the healthy minimum of 5. It has increased from 0.75 (Mar 24) to 1.56, marking an increase of 0.81.
- For Diluted EPS (Rs.), as of Mar 25, the value is 1.56. This value is below the healthy minimum of 5. It has increased from 0.75 (Mar 24) to 1.56, marking an increase of 0.81.
- For Cash EPS (Rs.), as of Mar 25, the value is 1.14. This value is below the healthy minimum of 3. It has increased from 0.95 (Mar 24) to 1.14, marking an increase of 0.19.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 14.73. It has increased from 12.47 (Mar 24) to 14.73, marking an increase of 2.26.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 14.73. It has increased from 12.47 (Mar 24) to 14.73, marking an increase of 2.26.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 17.31. It has decreased from 37.14 (Mar 24) to 17.31, marking a decrease of 19.83.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 1.64. This value is below the healthy minimum of 2. It has decreased from 1.91 (Mar 24) to 1.64, marking a decrease of 0.27.
- For PBIT / Share (Rs.), as of Mar 25, the value is 1.58. This value is within the healthy range. It has decreased from 1.71 (Mar 24) to 1.58, marking a decrease of 0.13.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.36. This value is within the healthy range. It has increased from 0.99 (Mar 24) to 1.36, marking an increase of 0.37.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1.08. This value is below the healthy minimum of 2. It has increased from 0.75 (Mar 24) to 1.08, marking an increase of 0.33.
- For PBDIT Margin (%), as of Mar 25, the value is 9.49. This value is below the healthy minimum of 10. It has increased from 5.14 (Mar 24) to 9.49, marking an increase of 4.35.
- For PBIT Margin (%), as of Mar 25, the value is 9.12. This value is below the healthy minimum of 10. It has increased from 4.59 (Mar 24) to 9.12, marking an increase of 4.53.
- For PBT Margin (%), as of Mar 25, the value is 7.85. This value is below the healthy minimum of 10. It has increased from 2.68 (Mar 24) to 7.85, marking an increase of 5.17.
- For Net Profit Margin (%), as of Mar 25, the value is 6.22. This value is within the healthy range. It has increased from 2.02 (Mar 24) to 6.22, marking an increase of 4.20.
- For Return on Networth / Equity (%), as of Mar 25, the value is 7.31. This value is below the healthy minimum of 15. It has increased from 6.03 (Mar 24) to 7.31, marking an increase of 1.28.
- For Return on Capital Employeed (%), as of Mar 25, the value is 10.51. This value is within the healthy range. It has decreased from 13.60 (Mar 24) to 10.51, marking a decrease of 3.09.
- For Return On Assets (%), as of Mar 25, the value is 6.15. This value is within the healthy range. It has increased from 3.64 (Mar 24) to 6.15, marking an increase of 2.51.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.16. This value is within the healthy range. It has decreased from 0.57 (Mar 24) to 0.16, marking a decrease of 0.41.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.39. It has decreased from 1.82 (Mar 24) to 1.39, marking a decrease of 0.43.
- For Current Ratio (X), as of Mar 25, the value is 6.21. This value exceeds the healthy maximum of 3. It has increased from 2.24 (Mar 24) to 6.21, marking an increase of 3.97.
- For Quick Ratio (X), as of Mar 25, the value is 3.73. This value exceeds the healthy maximum of 2. It has increased from 1.33 (Mar 24) to 3.73, marking an increase of 2.40.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.25. This value is below the healthy minimum of 4. It has decreased from 4.58 (Mar 24) to 3.25, marking a decrease of 1.33.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 7.44. This value is within the healthy range. It has increased from 2.70 (Mar 24) to 7.44, marking an increase of 4.74.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 5.88. This value is within the healthy range. It has increased from 2.06 (Mar 24) to 5.88, marking an increase of 3.82.
- For Enterprise Value (Cr.), as of Mar 25, the value is 56.46. It has increased from 36.45 (Mar 24) to 56.46, marking an increase of 20.01.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.85. This value is below the healthy minimum of 1. It has increased from 0.72 (Mar 24) to 0.85, marking an increase of 0.13.
- For EV / EBITDA (X), as of Mar 25, the value is 9.05. This value is within the healthy range. It has decreased from 14.08 (Mar 24) to 9.05, marking a decrease of 5.03.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.94. This value is below the healthy minimum of 1. It has increased from 0.54 (Mar 24) to 0.94, marking an increase of 0.40.
- For Price / BV (X), as of Mar 25, the value is 1.11. This value is within the healthy range. It has decreased from 1.63 (Mar 24) to 1.11, marking a decrease of 0.52.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.94. This value is below the healthy minimum of 1. It has increased from 0.54 (Mar 24) to 0.94, marking an increase of 0.40.
- For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.06, marking an increase of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Narmada Agrobase Ltd:
- Net Profit Margin: 6.22%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 10.51% (Industry Average ROCE: 15.13%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 7.31% (Industry Average ROE: 13.39%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 5.88
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.73
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 21.1 (Industry average Stock P/E: 21.43)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.16
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.22%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Animal/Shrimp Feed | 613/P-1 IJ, Pura (Jethaji) Dhanpura Road, Mehsana Gujarat 384421 | infonarmadaagrobase@gmail.com http://www.narmadaagrobase.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Neerajkumar Sureshchandra Agrawal | Managing Director |
| Mr. Suresh Chandra Gupta | Whole Time Director |
| Ms. Pooja Aidasani | Ind. Non-Executive Director |
| Mr. Ganesh Bhavarlal Prajapati | Ind. Non-Executive Director |
| Mrs. Nidhi Dineshbhai Patel | Ind. Non-Executive Director |
| Mr. Gaurav Dineshkumar Agarwal | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Narmada Agrobase Ltd?
Narmada Agrobase Ltd's intrinsic value (as of 08 November 2025) is 28.35 which is 24.34% higher the current market price of 22.80, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 86.4 Cr. market cap, FY2025-2026 high/low of 28.4/14.6, reserves of ₹17.93 Cr, and liabilities of 66.46 Cr.
What is the Market Cap of Narmada Agrobase Ltd?
The Market Cap of Narmada Agrobase Ltd is 86.4 Cr..
What is the current Stock Price of Narmada Agrobase Ltd as on 08 November 2025?
The current stock price of Narmada Agrobase Ltd as on 08 November 2025 is 22.8.
What is the High / Low of Narmada Agrobase Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Narmada Agrobase Ltd stocks is 28.4/14.6.
What is the Stock P/E of Narmada Agrobase Ltd?
The Stock P/E of Narmada Agrobase Ltd is 21.1.
What is the Book Value of Narmada Agrobase Ltd?
The Book Value of Narmada Agrobase Ltd is 14.7.
What is the Dividend Yield of Narmada Agrobase Ltd?
The Dividend Yield of Narmada Agrobase Ltd is 0.00 %.
What is the ROCE of Narmada Agrobase Ltd?
The ROCE of Narmada Agrobase Ltd is 13.0 %.
What is the ROE of Narmada Agrobase Ltd?
The ROE of Narmada Agrobase Ltd is 11.2 %.
What is the Face Value of Narmada Agrobase Ltd?
The Face Value of Narmada Agrobase Ltd is 10.0.